Literature DB >> 4051122

Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study.

V V Kakkar, D Lawrence.   

Abstract

This prospective study was undertaken in 153 patients who had sustained DVT of various extents and had been treated with streptokinase or heparin. Its aim was (1) to assess hemodynamic changes occurring in the deep venous system over a 2 year period, and (2) to correlate these hemodynamic changes with the clinical features that subsequently developed. Foot volumetry, a noninvasive, objective, and accurate technique, was used to measure hemodynamic changes. Within 2 years of DVT, there was severe hemodynamic impairment (equivalent to that seen in established postphlebitic limbs) in a fifth of the limbs with calf vein DVT, and in half of the limbs with more extensive proximal DVT. Symptoms were worse after major DVT. Even when successful, thrombolytic therapy does not prevent hemodynamic deterioration. The results appear to be no better than for a group of patients who, with the same degree of thrombosis, received heparin therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051122

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

Review 1.  Use of plasminogen activators in venous thrombosis.

Authors:  J Hirsh; A G Turpie
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

3.  Future prospects in the treatment of venous disease.

Authors:  E F Bernstein
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

Review 4.  Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences.

Authors:  A J Comerota
Journal:  Cardiovasc Intervent Radiol       Date:  1988       Impact factor: 2.740

Review 5.  Distal deep vein thrombosis: what's the best treatment?

Authors:  L R Powers
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

Review 6.  Thrombolytic treatment and new calcium antagonists.

Authors:  J Feely; T Pringle; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

Review 7.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

8.  Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis.

Authors:  L A Lenert; R M Soetikno
Journal:  J Am Med Inform Assoc       Date:  1997 Jan-Feb       Impact factor: 4.497

Review 9.  Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life.

Authors:  S R Kahn; S Solymoss; D L Lamping; L Abenhaim
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

Review 10.  Anticoagulation therapy for venous thromboembolism.

Authors:  David K Cundiff
Journal:  MedGenMed       Date:  2004-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.